People: Endo International PLC (ENDP.OQ)

ENDP.OQ on NASDAQ Stock Exchange Global Select Market

10:48pm IST
Change (% chg)

$0.00 (+0.14%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Maletta, Matthew 

Mr. Matthew Joseph Maletta is an Executive Vice President, Chief Legal Officer of Endo International Public Limited Company. and has global responsibility for all legal matters affecting the Company. Prior to joining Endo in 2015, Mr. Maletta served as Vice President, Associate General Counsel and Corporate Secretary of Allergan. In this position, he served as an advisor to the Chief Executive Officer and Board of Directors and supervised several large transactions, including the $70 billion acquisition of Allergan by Actavis in 2015. Mr. Maletta also played a key role defending Allergan from an unsolicited takeover bid by Valeant Pharmaceuticals and Pershing Square Capital Management in 2014. Mr. Maletta joined Allergan in 2002 and during his tenure, held roles of increased responsibility, including serving as the lead commercial attorney for Allergan’s aesthetics businesses for several years and as Head of Human Resources in 2010. Prior to joining Allergan, Mr. Maletta was in private practice, focusing on general corporate matters, finance, governance, securities and transactions. He holds a B.A. degree in political science from the University of Minnesota, summa cum laude and Phi Beta Kappa, and a J.D. degree, cum laude, from the University of Minnesota Law School..

Basic Compensation

Total Annual Compensation, USD 1,788,550
Restricted Stock Award, USD 1,606,930
Long-Term Incentive Plans, USD --
All Other, USD 33,152
Fiscal Year Total, USD 3,428,640

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --